Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers. - Wikidata - awgldk - TriplyDB

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.

http://www.wikidata.org/entity/Q37408259

about

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.

http://www.wikidata.org/entity/Q37408259

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.

@en

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.

@nl

type

label

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.

@en

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.

@nl

prefLabel

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.

@en

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.

@nl

P1433

Q37408259-C9E3764B-4F8D-4BFB-B1F3-7AEACF490AA5

P1476

Q37408259-F51E6FA5-AF5C-4BC2-BEC8-5583AD0E4C35

P2093

Q37408259-030006D6-7CB9-4C81-8B5E-72349ABF8CC9

Q37408259-1D62798A-E79D-4995-BCF7-EC80C77A0E05

Q37408259-7002DA23-8E95-4727-91BF-4E7CDF6B9C90

Q37408259-99AADAD9-7157-4C3F-8FCF-8F522D7C0808

Q37408259-9F849E6C-409F-4454-BA4D-1EFA6B6E2CFC

Q37408259-A48A885E-BF42-431E-98B7-C6AC0D42F3F9

Q37408259-B312EEFC-E5DE-4FE6-8C4F-315AD0D76314

Q37408259-BD54689D-0F94-4B67-9193-6096877D80B1

Q37408259-C4C7179E-5501-4A57-90DA-FD96B45ED386

Q37408259-C99FB325-7D2D-4348-A479-DDAB13619E9E

P2860

Q37408259-1283DCD4-3AE2-4D4E-8523-0F0CC203C739

Q37408259-221C35A2-D39E-4CA5-A5F7-508D46CEB561

Q37408259-35F7D10C-9E78-4306-91DF-7A98334B2863

Q37408259-36F6D643-F558-4279-B78C-9F94694EB3B1

Q37408259-6C3921A7-9584-40A4-8EFD-0E538D156767

Q37408259-CC7AA98A-14D1-4CD2-B09C-C75A155BB1B8

Q37408259-D2332360-F45D-49D2-AFB3-E13E499EB6D1

Q37408259-E3B4259C-4930-4F49-B6E1-5D7F3B08F686

Q37408259-F1EA0F49-42DB-4F76-8739-72F22FBAE4E1

P2888

Q37408259-D19BFD6F-1916-4251-B63D-E487CB4340B7

P304

Q37408259-EF6BDC72-562C-413B-A501-C95948DDC5D0

P31

Q37408259-24C1134A-9F8D-4DC7-AE8D-153B90449F78

P356

Q37408259-BC6454EA-787A-4AFE-9001-76FC2A53C297

P407

Q37408259-F7F578CD-6994-4648-8774-05CF23AE8580

P433

Q37408259-F941BC20-6F7A-4AD1-BDA7-E3682DC813E6

P478

Q37408259-74888596-FFE9-47F6-BA0B-2416D57F6814

P50

Q37408259-2580E5B4-3D38-4635-A4FD-2C3E51C8C7A3

P577

Q37408259-CC4B2C25-9618-4CD7-8DE2-F5806AC12948

P698

Q37408259-F28FA743-7B05-4564-AE47-6C3CA9D541B5

P921

Q37408259-382053FB-582E-4E2E-92BD-9E870539CCED

P932

Q37408259-62DA60C8-F221-461A-AE82-2DE726CC329E

P356

P1433

British Journal of Cancer

P1476

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.

@en

P2093

Brigitte F M Slangen

http://www.w3.org/2001/XMLSchema#string

Hans F A Vasen

http://www.w3.org/2001/XMLSchema#string

Helena C van Doorn

http://www.w3.org/2001/XMLSchema#string

Joanne A de Hullu

http://www.w3.org/2001/XMLSchema#string

Katja N Gaarenstroom

http://www.w3.org/2001/XMLSchema#string

Leendert H Zaaijer

http://www.w3.org/2001/XMLSchema#string

Luc R C W van Lonkhuijzen

http://www.w3.org/2001/XMLSchema#string

Marc van Beurden

http://www.w3.org/2001/XMLSchema#string

Marian J E Mourits

http://www.w3.org/2001/XMLSchema#string

Mieke Kriege

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer

Cancer Incidence in BRCA1 mutation carriers.

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.

Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer.

The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.

Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients.

Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands.

P2888

P304

1174-1178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2016.333

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Caroline Seynaeve

P577

2016-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27755534

http://www.w3.org/2001/XMLSchema#string

P921

P932

5104898

http://www.w3.org/2001/XMLSchema#string